ISSN:

Journal Home

Biomarker Insights Q2 Unclaimed

Libertas Academica Ltd. New Zealand

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Biomarker Insights is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 38. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1663,2 €. The scope of the journal is focused on biomarker, genes, markers, protein, pathway. It has an SJR impact factor of 0,878 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,878.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Biochemistry (medical) (Q2) Molecular Medicine (Q2) Pharmacology (Q2)

Price

1663,2 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,878

SJR Impact factor

38

H Index

32

Total Docs (Last Year)

51

Total Docs (3 years)

2034

Total Refs

179

Total Cites (3 years)

44

Citable Docs (3 years)

3.46

Cites/Doc (2 years)

63.56

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Drug Safety - Case Reports Q2
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Q2
Expert Review of Anticancer Therapy Q2
American Journal of Cardiovascular Drugs Q2
Infection and Drug Resistance Q2

Compare this journals

Aims and Scope

Biomarker Genes Markers Protein Pathway